Can we do without mydriasis in multifocal ERG recordings?
The purpose of this study is to determine whether mfERG recordings with natural pupils approximate recordings obtained in mydriasis if the stimulus luminance is adjusted. If so, a bright monitor could obviate pupil dilation, rendering clinical management considerably easier. In 11 eyes of six subjects, we took four mfERG recordings with a resolution of 61 scaled hexagons per eye, two with natural pupils and two in mydriasis with a luminance of 150 cd/m(2) and 500 cd/m(2), respectively. Conditions will be abbreviated as "LoNat, HiNat, LoDil, and HiDil," where Lo/Hi stands for low vs. high luminance and Nat/Dil stands for natural vs. dilated pupils. Response densities and peak times were averaged for the central seven and the remaining 54 hexagons. An ANOVA found highly significant effects for both amplitude and peak time between the four recording conditions (P always <0.001). However, for the two "middle" conditions, HiNat and LoDil, amplitudes and peak times did not differ markedly. Retinal illuminances of the conditions LoNat and HiNat each differed from the conditions LoDil and HiDil, respectively, by a factor of 5.4. Amplitudes increased and peak times decreased in the order of conditions LoNat, HiNat, LoDil, HiDil. When data were corrected for the Stiles-Crawford effect, there was an inversion of effective retinal illuminances of the recordings HiNat and LoDil. The mfERG guidelines correspond to the condition LoDil; for all practical purposes, the amplitudes and peak times are the same when the HiNat condition is used. Thus, when clinical constraints render pupil dilation undesirable, the mfERG can be recorded with natural pupils when monitor luminance is increased by five times (if available).
Poloschek
Charlotte M
CM
Sektion Funktionelle Sehforschung, Universitäts-Augenklinik, Killianstr. 5, 79106 Freiburg, Germany. charlotte.poloschek@uniklinik-freiburg.de
Bach
Michael
M
D000328:Adult; D000704:Analysis of Variance; D004596:Electroretinography / Q000379:methods*; D006801:Humans; D008029:Lighting / Q000379:methods; D009184:Mydriatics / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D010775:Photic Stimulation / Q000379:methods; D011680:Pupil / Q000187:drug effects / Q000502:physiology; D013997:Time Factors; D014331:Tropicamide / Q000494:pharmacology
D009184:Mydriatics; D010656:Phenylephrine; D014331:Tropicamide
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Jun 19;206(4):237-45
308328
J Opt Soc Am. 1960 Aug;50:780-4
13842659
Vision Res. 1992 Mar;32(3):433-46
1604830
Jpn J Ophthalmol. 2000 Mar-Apr;44(2):122-7
10715377
J Opt Soc Am A. 1993 Jul;10(7):1611-23
8350150
Br J Ophthalmol. 1998 Aug;82(8):971-3
9828786
JAMA. 2000 Dec 20;284(23):3043-5
11122593
Doc Ophthalmol. 2006 Nov;113(3):187-92
17109159
Doc Ophthalmol. 2008 Jan;116(1):1-11
17972125
Doc Ophthalmol. 1999;99(1):41-54
10947008
Ophthalmic Physiol Opt. 1992 Apr;12(2):137-41
1408159
Doc Ophthalmol. 2004 Jul;109(1):67-72
15675201